Search for Loan Search for Card Search for Insurance Search for Investment Search for Stocks Search for Credit Card Search for Personal loan Search for IPO Search for Indices

Customer Portal

EMI Card

Download

Steal Deals

BAJAJ FINSERV DIRECT LIMITED

Market Insights

Astonea Labs IPO Scheduled for May 27 Opening, Aims to Raise ₹37.67 Crore

Roshani Ballal Posted on May 27, 2025

Table of Contents

Astonea Labs, a company that makes medicines and beauty products under contract for other businesses (this is called contract manufacturing), is getting ready to offer its shares to the public for the first time. This offering, known as an Initial Public Offering (IPO), is for Small and Medium Enterprises (SMEs). The company works with clients in India and other countries.

The Astonea Labs IPO is a book-built issue planned to raise ₹37.67 Crore. This amount will come entirely from selling 27.9 lakh new shares of the company, meaning no shares are being sold by existing owners. The money raised is intended for several uses, including paying for registration steps in Bolivia, buying and setting up machinery for making ointments, funding advertising and marketing efforts, investing in necessary computer equipment, covering daily business costs (working capital needs), and other general company purposes.

Price Band and Lot Size

Price Range: ₹128 to ₹135 per share
Minimum Application: 1,000 shares (1 lot)
For retail investors, the minimum and maximum application is 1 lot, amounting to ₹1.35 Lakh at the highest price.
High Net-Worth Individuals (HNIs) must apply for at least 2 lots (2,000 shares), requiring an investment of ₹2.7 Lakh.

IPO Timeline

Refer the following table

Event	Date
IPO Opens	May 27
IPO Closes	May 29
Allotment Finalisation	May 30 (Friday)
Refunds Begin	June 2
Shares Credited to Demat Accounts	June 2
Listing on BSE SME Platform	June 3 (Tuesday)

Astonea Labs has set aside shares for different types of investors. Up to 50% of the total shares are for big professional investors (Qualified Institutional Buyers). At least 35% are reserved for individual investors (retail investors). A minimum of 15% will be given to other large investors who are not institutions (Non-Institutional Investors).

The company plans for its shares to begin trading on the BSE SME stock platform on Tuesday, June 3. Oneview Corporate Advisors Pvt. Ltd. is managing the IPO book-building process, and Kfin Technologies Limited is the official registrar for the issue.

Financially, Astonea Labs reported revenue of ₹80.29 crore in the financial year ending March 2024 (FY24), an increase from ₹67.26 crore in the previous year (FY23). The company's profit after tax also showed significant growth, rising to ₹3.81 Crore in FY24 from ₹67 Lakh in FY23.

Astonea Labs' business includes making and selling various pharmaceutical products like antibiotics, cold remedies, and medicines for diabetes, heart issues, and infections. They also make skin, dental, and hair care products. Additionally, they supply packaging and raw materials to other manufacturers.

Note: Investing in IPOs involves risks. Investors should consult with financial advisors and carefully read the official documents before investing.

Disclaimer: This content is for informational purposes only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.

Hi! I’m Roshani Ballal

Blogger

Roshani has over 6 years of experience and has honed her skills in performance content marketing in the financial domain. She loves diving into research and has crafted and overviewed creative copies, long-form financial content, engaging blogs, and informative articles. She specialises in delivering user-oriented content and solving problems through various content formats. On the side, Roshani enjoys writing poems-that's how she stays creative when she is not crunching numbers.